Acacia Research Corporation — 2012 Form 10-K
Reporting period: Fiscal year ended December 31, 2012. The filing also provides unaudited quarterly results, including the quarter ended December 31, 2012. Acacia acquires, licenses and enforces patent rights; revenue depends substantially on licensing agreements and enforcement outcomes.
Financial results and liquidity
| Metric | 2012 | 2011 |
|---|---|---|
| Revenue | $250.7 million | $172.3 million |
| Verdict insurance proceeds / total operating income | None / $250.7 million | $12.5 million / $184.7 million |
| Operating income | $80.4 million | $30.3 million |
| Net income attributable to Acacia | $59.5 million | $21.1 million |
| Diluted earnings per share | $1.24 | $0.51 |
| Operating cash flow | $104.6 million | $60.6 million |
| Cash, cash equivalents and investments at year-end | $311.3 million | $323.3 million |
| Working capital at year-end | $302.6 million | $294.9 million |
| Total assets / total liabilities at year-end | $668.7 million / $50.2 million | $352.9 million / $30.8 million |
Reported operating margin was approximately 32.1% in 2012 versus 16.4% in 2011; net margin was approximately 23.7% versus 11.4%, respectively. These ratios use reported total operating income, including 2011 verdict insurance proceeds. Acacia had no long-term debt, committed credit lines or significant off-balance-sheet financing arrangements other than operating leases.
Fourth-quarter 2012 revenue was $66.3 million, operating income $14.7 million and net income attributable to Acacia $9.8 million. In fourth-quarter 2011, revenue was $20.8 million, operating loss $4.9 million and net loss $4.2 million.
Changes and notable items
- Annual revenue rose 46% on a core-revenue basis; total revenues and other operating income rose 36%. Management attributed the increase primarily to higher average revenue per executed agreement and more agreements. Agreements numbered 138 in 2012 versus 125 in 2011.
- Operating costs and expenses increased to $170.3 million from $142.0 million. Patent amortization rose to $39.0 million from $9.7 million, and marketing, general and administrative expense rose to $54.1 million from $35.7 million. Non-cash stock compensation was $25.7 million, up from $13.6 million.
- Acacia acquired ADAPTIX in January 2012 for approximately $160 million in cash, including $10 million cash acquired, adding a 4G wireless patent portfolio. It acquired 55 new portfolios during the year and reported total patent acquisition costs of $328.3 million, including ADAPTIX.
- Operating cash flow improved, but investing activities used $408.8 million, principally for ADAPTIX, patent acquisitions and investment purchases. Financing provided $211.3 million, including $219.0 million net proceeds from a private stock placement; Acacia also repurchased $26.7 million of shares.
- The 2012 tax provision was $22.1 million, including $11.9 million in foreign withholding taxes. Release of a valuation allowance generated a $10.7 million tax benefit. The effective tax rate reported was 27%.
Outlook, risks and contingencies
Management said available cash, investments, anticipated operating cash flows and other available credit should meet cash requirements through at least March 2014 and for the foreseeable future. The filing gives no specific revenue or earnings guidance. Acacia expects licensing revenue and legal expenses to remain variable and says quarterly results should not be relied on as indicative of future periods.
- Results depend on the timing and value of licensing agreements, litigation outcomes, collections, royalty reports and licensee activity. Four licensees represented 55% of 2012 revenue; three represented 89% of year-end receivables.
- Patent litigation can be costly, slow and unpredictable. Adverse rulings, sanctions or awards of defendants’ legal fees could materially affect results. Management considered ordinary-course claims and counterclaims not likely to have a material effect, while acknowledging potential material sanctions in enforcement actions.
- Patent-law changes, including the America Invents Act provisions taking effect in March 2013, could increase enforcement costs or uncertainty. Competition, technology obsolescence, patent impairment and difficulty sourcing new portfolios are additional risks.
- The $12.5 million verdict insurance recovery recognized in 2011 followed reversal of a patent infringement judgment against Yahoo!; it did not recur in 2012.
- The IRS was auditing Acacia’s 2010 federal consolidated tax return; no findings or adjustments had been proposed. Unrecognized tax benefits were approximately $2.1 million. The filing also describes potential tax exposure related to the prior CombiMatrix split-off.
Investor verification priorities
- Review the largest license agreements, revenue concentration and whether year-end receivables were collected as expected.
- Assess the returns and remaining cash requirements of ADAPTIX and other patent acquisitions against the substantial increase in patent amortization.
- Examine litigation developments, legal spending and any potential sanctions or adverse patent rulings.
- Verify liquidity and capital deployment after the 2012 acquisition spending, equity issuance and share repurchases; note that the repurchase authorization ran through May 15, 2013.
- Evaluate the sustainability of earnings, including the 2011 insurance proceeds, 2012 tax benefit, stock-based compensation and licensing-related cost variability.